Fentanyl Transdermal Patch, Extended Release
Product Images NDC 0406-9100

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Fentanyl Transdermal (NDC 0406-9100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fentanyl Transdermal System 1)

Chemical structure diagram of fentanyl, the active ingredient in FENTANYL TRANSDERMAL patch. The diagram shows fentanyl's molecular formula C22H28N2O and molecular weight 336.5.*

FDA Label Image

Principal Display Panel (50 mcg/hr)

FENTANYL TRANSDERMAL SYSTEM 50 mcg/hr extended-release transdermal patch packaging label. The label indicates a 72-hour delivery of 50 mcg/hr fentanyl, includes warnings about use by opioid-tolerant patients only, and states the product is for prescription use. The labeler is Mallinckrodt. The box contains five systems.*

FDA Label Image

Principal Display Panel (62.5 mcg/hr)

FENTANYL TRANSDERMAL SYSTEM 62.5 mcg/hr patch packaging label showing extended-release transdermal system. Includes strength 62.5 mcg/hr and warnings about use only for opioid-tolerant patients. Labeler is Mallinckrodt. The label also includes NDC 0406-9062-76, dosing information, and safety cautions.*

FDA Label Image

Principal Display Panel (75 mcg/hr)

FENTANYL TRANSDERMAL SYSTEM 75 mcg/hr patch, extended release, transdermal delivery by SpecGx LLC. The label shows a carton for five 75 mcg/hr fentanyl transdermal systems. It includes dosing and safety warnings, stating it is for opioid-tolerant patients only and contains 8.25 mg fentanyl per system. The label displays the NDC 0406-9075-76 and emphasizes it is Rx only with detailed usage cautions.*

FDA Label Image

Principal Display Panel (100 mcg/hr)

Packaging label for FENTANYL TRANSDERMAL SYSTEM 100 mcg/hr patch, extended release, by SpecGx LLC. The label indicates this human prescription drug contains 100 mcg/hr fentanyl for transdermal delivery over 72 hours. The carton holds five systems and includes warnings that it is for opioid-tolerant patients only and requires a pharmacist to dispense the medication separately to each patient.*

FDA Label Image

Principal Display Panel (12 mcg/hr)

Fentanyl Transdermal System 12 mcg/hr patch extended-release transdermal delivery system by SpecGx LLC. The label indicates 12 mcg/hr strength with instructions noting prescription-only status and warnings about life-threatening breathing problems. The package is labeled for opioid-tolerant patients only and includes manufacturer information from Mallinckrodt.*

FDA Label Image

Principal Display Panel (25 mcg/hr)

Label for Fentanyl Transdermal System 25 mcg/hr patch, an extended-release transdermal dosage form by Mallinckrodt. The label includes warnings restricting use to opioid-tolerant patients only and specifies a 72-hour delivery time. The NDC is 0406-9125-76. The label also carries a pharmacy dispensing reminder and visual design with red, white, and blue colors.*

FDA Label Image

Principal Display Panel (50 mcg/hr)

Label for FENTANYL TRANSDERMAL SYSTEM 50 mcg/hr patch, extended release transdermal dosage form by SpecGx LLC. The label includes the product name, strength (50 mcg/hr), prescription-only status, a boxed warning about serious respiratory risks, usage cautions, and storage instructions. The label shows NDC 0406-9150-76 and includes branding from Mallinckrodt, highlighting the product is for opioid-tolerant patients only.*

FDA Label Image

Principal Display Panel (75 mcg/hr)

Fentanyl Transdermal System 75 mcg/hr patch, extended-release transdermal delivery. The label highlights usage restrictions, safety warnings, and dosage (75 mcg/hr for 72 hours). Manufactured by Mallinckrodt and labeled by SpecGx LLC, it includes packaging details such as the National Drug Code (NDC 0406-9175-76) and specific safety instructions for opioid-tolerant patients only.*

FDA Label Image

Principal Display Panel (100 mcg/hr)

The image is a packaging label for Fentanyl Transdermal System 100 mcg/hr extended-release transdermal patches by Mallinckrodt, distributed by SpecGx LLC. The label indicates a package containing five patches, each delivering 100 mcg/hr of fentanyl for 72 hours. It includes dosage details, safety warnings about breathing problems, and usage restrictions for opioid-tolerant patients only. The label also shows an NDC code, barcodes, and a red warning band stating 'For Opioid-Tolerant Patients Only.'*

FDA Label Image

Fentanyl Transdermal System Rectangular Unit (Fentanyl Transdermal System 2)

An illustration showing the cross-section of a fentanyl transdermal patch labeled with its components including the backing film, drug containing layer, rate controlling membrane, skin adhesive layer, and protective liner.*

FDA Label Image

Serum Fentanyl Concentrations (Fentanyl Transdermal System 3)

A line graph depicting serum fentanyl concentrations (ng/mL) over time (hours) following single and multiple applications of a Fentanyl Transdermal System 100 mcg/hr. Two datasets are shown: one for a single application (1x) and one for multiple applications (4x), with concentration measured up to around 340 hours. The graph includes error bars representing variability in measurements.*

FDA Label Image

Parts Of The Fentanyl Transdermal System (Fentanyl Transdermal System 4)

An instructional diagram illustrating the cross-sectional layers of a fentanyl transdermal patch. The layers from top to bottom are labeled as backing film, drug containing layer, rate controlling membrane, skin adhesive layer, and protective liner. The diagram visually explains the patch's structural components.*

FDA Label Image

Figures 1 To 8 (Fentanyl Transdermal System 5)

Instructional images showing the application of a fentanyl transdermal patch on a male torso. Steps include placing the patch on the upper chest and back, hair clipping around the application site, peeling the patch backing, pressing it firmly on the skin, and ensuring proper adhesion to the chest.*

FDA Label Image

Images 9 And 10 (Fentanyl Transdermal System 6)

This image includes two black and white instructional illustrations labeled Figures 9 and 10. Figure 9 shows hands peeling a protective liner from a transdermal patch, and Figure 10 shows a person disposing of the used patch in a toilet. The illustrations are related to the proper use and disposal of a fentanyl transdermal patch.*

FDA Label Image

Principal Display Panel (12 mcg/hr)

Fentanyl Transdermal System 12 mcg/hr extended-release transdermal patch packaging label. The label indicates a package containing five systems, each delivering 12 mcg/hr of fentanyl over 72 hours. It displays warnings about respiratory risks and opioid tolerance, with directions for prescription use only. The labeler is Mallinckrodt. The design features dark blue, red, and white colors with dosage and safety information prominently shown.*

FDA Label Image

Principal Display Panel (25 mcg/hr)

FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr patch carton label with a red and white color scheme. The label shows the product name, strength (25 mcg/hr), and federal schedule II symbol. It states Rx only and includes warnings about serious breathing problems and usage restrictions for opioid-tolerant patients. The label is marked for a package size of five systems and is labeled by Mallinckrodt and SpecGx LLC.*

FDA Label Image

Principal Display Panel (37.5 mcg/hr)

Packaging label for Fentanyl Transdermal System 37.5 mcg/hr extended release patch by SpecGx LLC. The label includes warnings about serious respiratory risks and usage restrictions, specifies dosage strength and delivery over 72 hours, and highlights that it is for opioid-tolerant patients only. It features the brand name Mallinckrodt and includes a barcode, NDC, and controlled substance schedule II marking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.